Transcranial Doppler (TCD) ultrasound detects changes in blood flow velocity inside the brain’s arteries, which makes it useful for identifying a surprisingly wide range of conditions: vasospasm after a brain bleed, narrowed arteries, tiny blood clots traveling through the bloodstream, holes in the heart, dangerously high pressure inside the skull, stroke risk in children with sickle cell disease, and even the cessation of brain blood flow in suspected brain death. It works by pressing a low-frequency ultrasound probe against thin areas of the skull and measuring how fast blood moves through specific arteries.
How TCD Works
TCD uses a 2 MHz ultrasound probe, a much lower frequency than the probes used for neck or abdominal scans. That lower frequency is necessary because higher-frequency waves can’t penetrate the skull bone. The probe is placed at one of four natural “windows” where the bone is thin enough to let sound through: the temple (the most commonly used), the eye socket, beneath the jaw, and the base of the skull at the back of the neck.
By bouncing sound waves off moving red blood cells, TCD calculates how fast blood is flowing through a given artery. Abnormally high velocities suggest a narrowed vessel (blood speeds up through tight spaces, like water through a pinched hose). Abnormally low or absent flow signals can indicate a blockage or loss of circulation. The test is painless, portable, and takes roughly 30 to 60 minutes, which makes it one of the few brain-imaging tools that can be done at the bedside and repeated as often as needed.
Vasospasm After a Brain Bleed
One of the most common uses of TCD is monitoring patients who have had a subarachnoid hemorrhage, a type of bleeding around the brain usually caused by a ruptured aneurysm. In the days following that bleed, arteries in the brain can go into spasm, clamping down and restricting blood flow enough to cause a stroke. TCD catches this early by tracking rising flow velocities before symptoms appear.
For the middle cerebral artery, the most frequently monitored vessel, a mean flow velocity at or above 120 cm/s is the threshold that raises concern for vasospasm. Hospitals typically perform TCD daily or every other day for the first two weeks after the hemorrhage. When velocities climb, the care team can intervene with treatments to relax the arteries or increase blood flow before permanent damage occurs. Studies comparing TCD readings to CT angiography show good agreement at that 120 cm/s cutoff, with a Cohen’s Kappa of 0.74, meaning TCD reliably flags the same cases that show up on more advanced imaging.
Intracranial Artery Narrowing
TCD can screen for stenosis, or narrowing, of the major arteries inside the skull. When an artery narrows by 50% or more, blood flow velocity at that point rises sharply. A mean flow velocity of 200 cm/s or higher is a commonly used threshold for significant stenosis. At that cutoff, TCD is highly specific (about 95%), meaning it rarely flags a problem that isn’t there. Its sensitivity is lower (around 29%), so it can miss some cases. Using a slightly lower velocity threshold of about 137.5 cm/s balances sensitivity and specificity better, catching roughly 72% of stenosis cases while still correctly ruling out 77% of normal arteries.
This makes TCD a useful first-pass screening tool, particularly for patients who need repeated monitoring. It won’t replace a CT or MR angiogram for a definitive diagnosis, but it can identify who needs that more detailed scan and track whether a known narrowing is getting worse.
Tiny Blood Clots and Emboli
TCD is uniquely capable of detecting microemboli, tiny clots or debris traveling through the brain’s arteries, in real time. These show up as brief, bright flashes on the monitor called high-intensity transient signals (HITS). To count as a true embolic signal, the flash must last less than 300 milliseconds, appear at least 3 decibels louder than the surrounding blood flow signal, and occur randomly throughout the heartbeat cycle. Each one produces a distinctive chirp or click sound through the speaker.
This capability is valuable during and after procedures like carotid artery surgery or heart valve replacement, where dislodged debris can travel to the brain. It’s also used in patients with atrial fibrillation or recently placed heart valves to gauge ongoing embolic risk. The presence of frequent microembolic signals can prompt changes in blood-thinning medication or surgical technique.
Patent Foramen Ovale (Heart Hole)
A patent foramen ovale, or PFO, is a small opening between the upper chambers of the heart that never fully closed after birth. About one in four adults has one. Most are harmless, but in some people, a PFO allows blood clots from the veins to bypass the lungs and travel directly to the brain, potentially causing a stroke. TCD combined with a “bubble study” is one of the best ways to detect this.
During the test, a small amount of agitated saline (which creates tiny microbubbles) is injected into a vein in the arm. If a PFO is present, those microbubbles cross from the right side of the heart to the left and show up on TCD as bright signals in the brain’s arteries. The Spencer grading scale classifies the shunt size by counting how many microbubbles appear: Grade 0 means none detected, Grade 1 is 1 to 10, Grade 2 is 11 to 30, Grade 3 is 31 to 100, Grade 4 is 101 to 300, and Grade 5 is more than 300. Higher grades suggest a larger opening, which can influence decisions about whether to close the PFO with a procedure.
Estimating Intracranial Pressure
TCD offers a noninvasive way to estimate pressure inside the skull. This matters for patients with traumatic brain injuries, large strokes, or brain swelling from other causes. The key measurement is the pulsatility index (PI), which captures the difference between peak and minimum flow velocities relative to the average. As pressure inside the skull rises, it compresses the arteries and makes the flow pattern more “spiky,” pushing the PI higher.
Research shows a strong enough correlation between PI and actual intracranial pressure (measured with invasive monitors) that clinicians can estimate pressure from the TCD reading alone. In the range of 5 to 40 mmHg, the estimate is accurate to within about 2.5 mmHg. This won’t replace a direct pressure monitor in critically ill patients, but it gives a quick, repeatable bedside check that requires no drilling into the skull.
Stroke Risk in Sickle Cell Disease
Children with sickle cell disease face a dramatically elevated risk of stroke, and TCD is the standard screening tool to identify those at highest risk. The landmark STOP trial established clear velocity categories: normal is below 170 cm/s, conditional (borderline) is 170 to 199 cm/s, and abnormal is 200 cm/s or higher. Children in the abnormal category have a stroke risk high enough to warrant regular blood transfusions, which the STOP trial showed could reduce that risk by over 90%.
Current guidelines recommend annual TCD screening for children with sickle cell disease starting at age 2. The test is painless and quick, making it practical for routine pediatric use. It remains one of the clearest examples of TCD directly changing patient outcomes.
Confirming Brain Death
When a patient is suspected of brain death, TCD can serve as a confirmatory test by demonstrating that blood has stopped circulating inside the brain. Two characteristic flow patterns indicate this: oscillating flow, where blood moves forward during the heartbeat and then reverses completely, resulting in no net flow; and systolic spikes, where brief, small forward pulses appear during each heartbeat but never actually push blood through. Both patterns indicate that intracranial pressure has risen so high that the brain’s circulation has effectively stopped.
Testing How Well Arteries Adapt
TCD can evaluate cerebral autoregulation, the brain’s ability to maintain steady blood flow despite changes in blood pressure or blood chemistry. One common method is the CO2 reactivity test: you breathe in slightly elevated levels of carbon dioxide (or simply hold your breath), and TCD measures how much the flow velocity changes. Healthy brain arteries dilate in response to rising CO2 and constrict when CO2 drops. A blunted response suggests the arteries have lost some of their ability to self-regulate, which can be a warning sign in conditions like severe head injury, carotid artery disease, or long-standing high blood pressure.
Limitations to Know About
TCD has one significant physical limitation: it requires a usable acoustic window. Between 8% and 20% of people lack a temporal window thin enough for the ultrasound to penetrate. This is more common in older adults (average age 75 in one study of window failure, compared to 67 in those with adequate windows) and in women, who tend to have thicker temporal bone. When the window is insufficient, the test simply can’t be performed.
TCD also measures velocity rather than directly imaging the arteries, so it can’t show exactly where a blockage sits or what it looks like. It’s best understood as a fast, portable, repeatable screening and monitoring tool rather than a replacement for CT or MR angiography when detailed anatomy matters.